DrugPatentWatch Database Preview
Profile for United States of America Patent: 9296753
US Patent Family Members and Approved Drugs for United States of America Patent: 9296753
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Oct 30, 2033 | Pharmacyclics Inc | IMBRUVICA | ibrutinib |
➤ Try a Free Trial | Aug 18, 2033 | Pharmacyclics Inc | IMBRUVICA | ibrutinib |
➤ Try a Free Trial | Jun 3, 2033 | Pharmacyclics Inc | IMBRUVICA | ibrutinib |
➤ Try a Free Trial | Jun 3, 2033 | Pharmacyclics Inc | IMBRUVICA | ibrutinib |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |